DARE — Dare Bioscience Inc · catalysts, narrative & risks

Snapshot (as of 2026‑10‑12)

Daré Bioscience (NASDAQ: DARE) is a San Diego–headquartered, micro‑cap women's health company founded in 2015 that describes itself as transitioning from a clinical‑stage developer to a multi‑product commercial women's health business [4], [19], [20]. As of Oct 12, 2026, the stock closed near $0.75 (down ~3% that day) with a market capitalization of roughly $14.75M on ~19.67M shares outstanding [14], [19]. An earlier snapshot placed market cap near $15.2M as of Oct 10, 2026 [background]. Critically, the share price has fallen approximately 64.6% over the trailing year [14] — a steep decline that deserves attention given the steady flow of positive corporate announcements. (Price data is provided for context, not as a recommendation.)

Recent Catalysts (last ~1–3 months)